Comparing Sequenom


Sequenom and Myriad Genetics are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, risk, institutional ownership, dividends, profitability and earnings. 46.0% of Sequenom shares are held by institutional investors.



from Biotech News